방사선 치료 장비 시장(2026-2030년)

The global radiation therapy equipment market is forecasted to grow by USD 1671.7 mn during 2025-2030, accelerating at a CAGR of 5.6% during the forecast period. The report on the global radiation therapy equipment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global cancer incidence, technological advancements in precision delivery, expansion of healthcare infrastructure and favorable reimbursement policies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global radiation therapy equipment market is segmented as below:

By End-User

• Hospitals
• ASCs
• Oncological treatment centers

By Product

• External
• Internal

By Application

• Breast cancer
• Prostate cancer
• Lung cancer
• Head and neck cancer

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the integration of ai in treatment planning as one of the prime reasons driving the global radiation therapy equipment market growth during the next few years. Also, shift toward outpatient care and specialized radiotherapy centers and advancements in image-guided and stereotactic delivery modalities will lead to sizable demand in the market.

The report on the global radiation therapy equipment market covers the following areas:

• Global radiation therapy equipment market sizing
• Global radiation therapy equipment market forecast
• Global radiation therapy equipment market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global radiation therapy equipment market vendors that include Acuitas Therapeutics, Alnylam Pharmaceuticals Inc., Arcturus Therapeutics Holdings, BioNTech SE, BOCSCI Inc., Creative Biolabs, Curapath, Esco Aster Pte. Ltd., Evonik Industries AG, Fujifilm Corp., Genevant Sciences Corp., Helix Biotech Inc., Merck KGaA, Moderna Inc., Northern RNA Inc., Pfizer Inc., Polymun, Precigenome LLC, Thermo Fisher Scientific Inc., Vernal Biosciences LLC. Also, the global radiation therapy equipment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Radiation Therapy Equipment Market 2020 - 2024
  • Historic Market Size - Data Table on Global Radiation Therapy Equipment Market 2020 - 2024 ($ million)
• 5.2 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.3 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.4 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global radiation therapy equipment market
• 6.2 Impact of geopolitical conflicts on global radiation therapy equipment market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by End-user

• 8.1 Market segments
• 8.2 Comparison by End-user
• 8.3 Hospitals - Market size and forecast 2025-2030
• 8.4 ASCs - Market size and forecast 2025-2030
• 8.5 Oncological treatment centers - Market size and forecast 2025-2030
• 8.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

9 Market Segmentation by Product

• 9.1 Market segments
• 9.2 Comparison by Product
• 9.3 External - Market size and forecast 2025-2030
• 9.4 Internal - Market size and forecast 2025-2030
• 9.5 Market opportunity by Product
  • Market opportunity by Product ($ million)

10 Market Segmentation by Application

• 10.1 Market segments
• 10.2 Comparison by Application
• 10.3 Breast cancer - Market size and forecast 2025-2030
• 10.4 Prostate cancer - Market size and forecast 2025-2030
• 10.5 Lung cancer - Market size and forecast 2025-2030
• 10.6 Head and neck cancer - Market size and forecast 2025-2030
• 10.7 Market opportunity by Application
  • Market opportunity by Application ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 India - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Colombia - Market size and forecast 2025-2030
  • 12.6.7 South Africa - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising global cancer incidence
  • Technological advancements in precision delivery
  • Expansion of healthcare infrastructure and favorable reimbursement policies
• 13.2 Market challenges
  • High capital costs and complex installation requirements
  • Shortage of skilled healthcare professionals
  • Stringent regulatory approvals and compliance burdens
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Integration of AI in treatment planning
  • Shift toward outpatient care and specialized radiotherapy centers
  • Advancements in image-guided and stereotactic delivery modalities

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Alnylam Pharmaceuticals Inc.
  • Alnylam Pharmaceuticals Inc. - Overview
  • Alnylam Pharmaceuticals Inc. - Product / Service
  • Alnylam Pharmaceuticals Inc. - Key offerings
  • SWOT
• 15.5 BioNTech SE
  • BioNTech SE - Overview
  • BioNTech SE - Product / Service
  • BioNTech SE - Key offerings
  • SWOT
• 15.6 BOCSCI Inc.
  • BOCSCI Inc. - Overview
  • BOCSCI Inc. - Product / Service
  • BOCSCI Inc. - Key offerings
  • SWOT
• 15.7 Creative Biolabs
  • Creative Biolabs - Overview
  • Creative Biolabs - Product / Service
  • Creative Biolabs - Key offerings
  • SWOT
• 15.8 Esco Aster Pte. Ltd.
  • Esco Aster Pte. Ltd. - Overview
  • Esco Aster Pte. Ltd. - Product / Service
  • Esco Aster Pte. Ltd. - Key offerings
  • SWOT
• 15.9 Evonik Industries AG
  • Evonik Industries AG - Overview
  • Evonik Industries AG - Business segments
  • Evonik Industries AG - Key news
  • Evonik Industries AG - Key offerings
  • Evonik Industries AG - Segment focus
  • SWOT
• 15.10 Fujifilm Corp.
  • Fujifilm Corp. - Overview
  • Fujifilm Corp. - Business segments
  • Fujifilm Corp. - Key offerings
  • Fujifilm Corp. - Segment focus
  • SWOT
• 15.11 Helix Biotech Inc.
  • Helix Biotech Inc. - Overview
  • Helix Biotech Inc. - Product / Service
  • Helix Biotech Inc. - Key offerings
  • SWOT
• 15.12 Merck KGaA
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key news
  • Merck KGaA - Key offerings
  • Merck KGaA - Segment focus
  • SWOT
• 15.13 Moderna Inc.
  • Moderna Inc. - Overview
  • Moderna Inc. - Product / Service
  • Moderna Inc. - Key offerings
  • SWOT
• 15.14 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Business segments
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
  • Pfizer Inc. - Segment focus
  • SWOT
• 15.15 Polymun
  • Polymun - Overview
  • Polymun - Product / Service
  • Polymun - Key offerings
  • SWOT
• 15.16 Precigenome LLC
  • Precigenome LLC - Overview
  • Precigenome LLC - Product / Service
  • Precigenome LLC - Key offerings
  • SWOT
• 15.17 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT
• 15.18 Vernal Biosciences LLC
  • Vernal Biosciences LLC - Overview
  • Vernal Biosciences LLC - Product / Service
  • Vernal Biosciences LLC - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations